Risk of demyelinating events associated with TNF-inhibitors compared with conventional synthetic disease modifying anti-rheumatic drugs in rheumatoid arthritis: Results from the French National Health Data System
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.